Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation IQWiG. Canagliflozin/metformin. Nutzenbewertung gemass Section 35a SGB V. [Canagliflozin/metformin. Benefit assessment according to section 35a Social Code Book V (dossier assessment)] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 255. 2014 Indexing Status Subject indexing assigned by CRD MeSH Administration, Oral; Blood Glucose; Diabetes Mellitus; Drug Therapy, Combination; Glomerular Filtration Rate; Glucosidess; Hemoglobin A, Glycosylated; Hypoglycemic Agents; Metformin; Sodium-Glucose Transporter 2; Thiophenes; Treatment Outcome Country of organisation Germany English summary There is no English language summary available. Address for correspondence IQWiG, Im Mediapark 8, DE-50670 Cologne, GERMANY, Tel: +49 (0) 221 - 35685 - 0, Fax: +49 (0) 221 - 35685 - 1 Email: berichte@iqwig.de AccessionNumber 32015000063 Date abstract record published 20/01/2015 |